Business
Nordson Corporation Reports Third Quarter Fiscal 2025 Results and Updates Full Year Guidance
Third Quarter Highlights: Sales were $742 million, an increase of 12% year-over-year Earnings per diluted share were $2.22 Adjusted earnings per diluted
About this update from Nordson Corporation
[{"type":"text","content":"\nThird Quarter Highlights:\n\n\n\nSales were $742 million, an increase of 12% year-over-year\n\n\n\n\nEarnings per diluted share were $2.22\n\n\n\n\nAdjusted earnings per diluted share were $2.73, up 13% year-over-year\n\n\n\n\nFree cash flow conversion of 180% of net income\n\n\n\n\nBoard of Directors approved a new $500 million share repurchase authorization\n\n\n\n WESTLAKE, Ohio--(BUSINESS WIRE)--\nNordson Corporation (Nasdaq: NDSN) today reported results for the fiscal third quarter ended July 31, 2025. Sales were $742 million compared to the prior year’s third quarter sales of $662 million. The third quarter 2025 sales included a favorable acquisition impact of 8%, an organic sales increase of 2% and a favorable currency translation impact of 2%.\n\n\nNet income was $126 million, or $2.22 of earnings per diluted share, compared to prior year’s third quarter net income of $117 million, or $2.04 of earnings per diluted share. Excluding charges associated with the exit of the medical contract manufacturing business and acquisition-related amortization and costs, third quarter adjusted net income was $155 million versus prior year adjusted net income of $138 million. Third quarter adjusted earnings per diluted share were $2.73, a 13% increase from the prior year adjusted earnings per diluted share of $2.41.\n\n\nEBITDA in the third quarter was $239 million, or 32% of sales, an increase of 15% compared to prior year EBITDA of $208 million, or 31% of sales.\n\n\nCommenting on the Company’s fiscal 2025 third quarter results, Nordson President and Chief Executive Officer Sundaram Nagarajan said, “The Nordson team responded effectively to dynamic demand conditions in key end markets and delivered on its promises, realizing solid year-over-year organic growth in the quarter. In particular, the Advanced Technology Solutions segment delivered 15% organic sales growth. Operational excellence drove strong profit performance, increasing adjusted earnings per share by 13% and EBITDA by 15%. In this final full quarter of Atrion’s first year acquisition performance, our new employees again exceeded expectations and contributed to both sales and earnings results. Also this quarter, we maintained a strong balance sheet, delivering cash flow conversion of 180% of net income that we used to reduce debt, repurchase shares and return dividends t...